
PFRMAT AL
TARGET T0121
AUTHOR 4035-9795-7731 
METHOD bioinbgu consensus 
MODEL  4
PARENT 1lfo
REMARK      bbbbbbb      b                      bbbbbbbbbb
REMARK  GYVGREVIFGIRPEDLYDAMF......ARVRVPGEN....LVRAVVEIVE
REMARK       |   |   |             | |   | |             |
REMARK  KVIHNEFTLG...EEEELETMTGEKVKAVVKMEGDNKMVTTFKGIKSVTE
REMARK  bbbbbbbbb        bbb   bbb    bbb  bbbbbbb  bbbbbb
REMARK  b   bbbbbbb   bbbbbbb   
REMARK  NLGSERIVHLRVGGVTFVGAFRSE
REMARK    |   |      |          
REMARK  FNG.DTITNTMTLGDIVYKRVSKR
REMARK  bb  bbbbbbbbb  bbbbbbbbb
REMARK TARGET  FROM-TO   FOLD       FROM-TO  ALIG No.
REMARK TALIGN SEQ 0    39  48  1LFO - 0     56  65  1.0 1
L 278 S 56
G 279 K 57
Y 280 V 58
V 281 I 59
G 282 H 60
R 283 N 61
E 284 E 62
V 285 F 63
I 286 T 64
F 287 L 65
REMARK TALIGN SEQ 0    52  59  1LFO - 0     66  73  1.0 1
P 291 G 66
E 292 E 67
D 293 E 68
Y 295 E 70
D 296 L 71
A 297 E 72
M 298 T 73
REMARK TALIGN SEQ 0    60  68  1LFO - 0     80  88  1.0 1
F 299 K 80
A 300 A 81
R 301 V 82
V 302 V 83
R 303 K 84
V 304 M 85
P 305 E 86
G 306 G 87
E 307 D 88
REMARK TALIGN SEQ 0    69  81  1LFO - 0     93 105  1.0 1
N 308 T 93
L 309 T 94
V 310 F 95
R 311 K 96
A 312 G 97
V 313 I 98
V 314 K 99
E 315 S 100
I 316 V 101
V 317 T 102
E 318 E 103
N 319 F 104
L 320 N 105
REMARK TALIGN SEQ 0    83 102  1LFO - 0    106 125  1.0 1
S 322 G 106
E 323 D 107
R 324 T 108
I 325 I 109
V 326 T 110
H 327 N 111
L 328 T 112
R 329 M 113
V 330 T 114
G 331 L 115
G 332 G 116
V 333 D 117
T 334 I 118
F 335 V 119
V 336 Y 120
G 337 K 121
A 338 R 122
F 339 V 123
R 340 S 124
S 341 K 125
TER
END

